Fluprednisolone | CAS#53-34-9 | glucocorticoid

MedKoo Cat#: 592533 | Name: Fluprednisolone

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Fluprednisolone is a synthetic glucocorticoid with anti-inflammatory properties.

Chemical Structure

Fluprednisolone

CAS#53-34-9

Theoretical Analysis

MedKoo Cat#: 592533

Name: Fluprednisolone

CAS#: 53-34-9

Chemical Formula: C21H27FO5

Exact Mass: 378.1843

Molecular Weight: 378.44

Elemental Analysis: C, 66.65; H, 7.19; F, 5.02; O, 21.14

Price and Availability

Size	Price	Availability	Quantity
25mg	USD 550.00	2 Weeks
100mg	USD 1,250.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

Fluprednisolone; Alphadrol; Etadrol; Isopredon; 6alpha-Fluoroprednisolone; Fluprednisolonum; Fluprednisolona; NSC 47439; NSC-47439; NSC47439

IUPAC/Chemical Name

Pregna-1,4-diene-3,20-dione, 6-fluoro-11,17,21-trihydroxy-, (6alpha,11beta)-

InChi Key

MYYIMZRZXIQBGI-HVIRSNARSA-N

InChi Code

InChI=1S/C21H27FO5/c1-19-5-3-11(24)7-14(19)15(22)8-12-13-4-6-21(27,17(26)10-23)20(13,2)9-16(25)18(12)19/h3,5,7,12-13,15-16,18,23,25,27H,4,6,8-10H2,1-2H3/t12-,13-,15-,16-,18+,19-,20-,21-/m0/s1

SMILES Code

C[C@@]12[C@](C(CO)=O)(O)CC[C@@]1([H])[C@]3([H])C[C@H](F)C4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 378.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Cho SH, Park JA, Zheng W, Abd El-Aty AM, Kim SK, Choi JM, Yi H, Cho SM, Afifi NA, Shim JH, Chang BJ, Kim JS, Shin HC. Quantification of bupivacaine hydrochloride and isoflupredone acetate residues in porcine muscle, beef, milk, egg, shrimp, flatfish, and eel using a simplified extraction method coupled with liquid chromatography-triple quadrupole tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Oct 15;1065-1066:29-34. doi: 10.1016/j.jchromb.2017.09.026. Epub 2017 Sep 19. PubMed PMID: 28946122. 2: Kaur S, Sukhija J. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2017 Mar;31(3):506. doi: 10.1038/eye.2016.243. Epub 2016 Nov 4. PubMed PMID: 27813525; PubMed Central PMCID: PMC5350369. 3: Wilson ME, Lambert SR, Plager DA, VanderVeen D, Roarty J, O'Halloran H. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2017 Mar;31(3):506-507. doi: 10.1038/eye.2016.244. Epub 2016 Nov 4. PubMed PMID: 27813524; PubMed Central PMCID: PMC5350370. 4: Komori T, Honda T, Irie H, Otsuka A, Kabashima K. Lichen Planus in Irradiated Skin During Nivolumab Treatment. Acta Derm Venereol. 2017 Mar 10;97(3):391-392. doi: 10.2340/00015555-2545. PubMed PMID: 27722767. 5: Shantha JG, Crozier I, Varkey JB, Kraft CS, Lyon GM 3rd, Mehta AK, Carlson RD, Hill CE, Kumar G, Debiec MR, Patel PS, Olsen TW, Nussenblatt RB, Martin DF, Ströher U, Uyeki TM, Ribner BS, Smith JR, Yeh S. Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor. Ophthalmology. 2016 Dec;123(12):2626-2628.e2. doi: 10.1016/j.ophtha.2016.07.013. Epub 2016 Sep 1. PubMed PMID: 27594198; PubMed Central PMCID: PMC5121070. 6: Lu S, Taban M. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease. Digit J Ophthalmol. 2016 Jun 28;22(2):54-7. doi: 10.5693/djo.02.2015.05.004. eCollection 2016. PubMed PMID: 27582676; PubMed Central PMCID: PMC4990084. 7: Feiler DL, Srivastava SK, Pichi F, Bena J, Lowder CY. RESOLUTION OF NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE. Retina. 2017 May;37(5):844-850. doi: 10.1097/IAE.0000000000001243. PubMed PMID: 27529841. 8: Wilson ME, O'Halloran H, VanderVeen D, Roarty J, Plager DA, Markwardt K, Gedif K, Lambert SR. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2016 Sep;30(9):1187-94. doi: 10.1038/eye.2016.132. Epub 2016 Jul 1. PubMed PMID: 27367745; PubMed Central PMCID: PMC5023802. 9: Ansai O, Shimomura Y, Fujimoto A, Sakai A, Tsuchida Y, Hayashi R, Shigehara Y, Hama N, Abe R. Case of pemphigus herpetiformis with immunoglobulin G autoantibodies against desmocollin-3. J Dermatol. 2017 Jan;44(1):104-105. doi: 10.1111/1346-8138.13451. Epub 2016 May 14. PubMed PMID: 27177601. 10: Symes RJ, Forooghian F. Topical difluprednate monotherapy for uveitic macular edema. Can J Ophthalmol. 2016 Feb;51(1):47-9. doi: 10.1016/j.jcjo.2015.10.007. PubMed PMID: 26874159. 11: Borrás T, Buie LK, Spiga MG. Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy. Gene Ther. 2016 May;23(5):438-49. doi: 10.1038/gt.2016.14. Epub 2016 Feb 8. PubMed PMID: 26855269; PubMed Central PMCID: PMC4860029. 12: Abu Samra K, Valdes-Navarro M, Lee S, Swan R, Foster CS, Anesi SD. A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab. Eur J Ophthalmol. 2016 Apr 12;26(3):e46-8. doi: 10.5301/ejo.5000724. PubMed PMID: 26692064. 13: Kolomeyer AM, Kodati S. Lamotrigine-induced tubulointerstitial nephritis and uveitis-atypical Cogan syndrome. Eur J Ophthalmol. 2015 Dec 1;26(1):e14-6. doi: 10.5301/ejo.5000674. PubMed PMID: 26350991. 14: Knych HK, Harrison LM, White A, McKemie DS. Disposition of isoflupredone acetate in plasma, urine and synovial fluid following intra-articular administration to exercised Thoroughbred horses. Drug Test Anal. 2016 Jan;8(1):141-7. doi: 10.1002/dta.1834. Epub 2015 Sep 1. PubMed PMID: 26333097. 15: Kaur S, Yangzes S, Singh S, Sachdev N. Efficacy and safety of topical difluprednate in persistent diabetic macular edema. Int Ophthalmol. 2016 Jun;36(3):335-40. doi: 10.1007/s10792-015-0121-3. Epub 2015 Aug 22. PubMed PMID: 26296375. 16: Ricer L. Malignant catarrhal fever in a Red Angus cow. Can Vet J. 2015 Jan;56(1):83-5. PubMed PMID: 25565720; PubMed Central PMCID: PMC4266062. 17: Cho H, Pillai P, Nicholson L, Sobrin L. Inflammatory Papillitis in Uveitis: Response to Treatment and Use of Optic Nerve Optical Coherence Tomography for Monitoring. Ocul Immunol Inflamm. 2016;24(2):194-206. doi: 10.3109/09273948.2014.991041. Epub 2014 Dec 30. PubMed PMID: 25549180. 18: Antoniazzi BF, Pires CW, Bresolin CR, Weiss RN, Praetzel JR. Antimicrobial activity of different filling pastes for deciduous tooth treatment. Braz Oral Res. 2015;29:1-6. Epub 2014 Dec 2. PubMed PMID: 25466327. 19: Giacobbe C, Palmisano G, Giovenzana GB, Giovannelli L, Negri R, Masciocchi N. Difluprednate: more than meets the eye. J Pharm Biomed Anal. 2015 Jan;102:305-13. doi: 10.1016/j.jpba.2014.09.028. Epub 2014 Sep 30. PubMed PMID: 25459928. 20: Jeng KW, Fine HF, Wheatley HM, Roth D, Connors DB, Prenner JL. Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate. Retina. 2014 Oct;34(10):1990-6. doi: 10.1097/IAE.0000000000000215. PubMed PMID: 25121927.